Lithium Monotherapy Increases ACTH and Cortisol Response in the Dex/CRH Test in Unipolar Depressed Subjects. A Study with 30 Treatment-Naive Patients
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Distorted activity of the hypothalamic-pituitary-adrenocortical (HPA) system is one of the most robustly documented biological abnormalities in major depression. Lithium is central to the treatment of affective disorders, but little is known about its effects on the HPA system of depressed subjects. OBJECTIVE: To assess the effects of lithium monotherapy on the HPA system of patients with major depression by means of the combined DEX/CRH test. METHOD: Thirty drug-naive outpatients with major depression (single episode or unipolar recurrent; SCID I- and II-confirmed) were treated with lithium monotherapy for four weeks. The DEX/CRH test was conducted directly before intake of the first lithium tablet and four weeks thereafter. Weekly ratings with the HDRS(21) were used to determine response (≥50% symptom reduction) and remission (HDRS ≤7). RESULTS: Lithium levels within the therapeutic range were achieved rapidly. Tolerability was good; no patient terminated the treatment prematurely. Response and remission rates were 50% and 33% respectively. Compared to the DEX/CRH test before the start of the treatment, a considerable and significant increase in all CRH-stimulated ACTH and cortisol parameters could be detected in the second DEX/CRH test. When analysed with particular regard to responders and non-responders, that significant increase was only present in the responders. CONCLUSIONS: We were able to demonstrate that lithium leads to a significant activation of the HPA system. This is possibly connected to stimulation of hypothalamic arginine vasoporessin (AVP), to direct intracellular effects of lithium on pituitary cells and to an induction of gene expression. TRIAL REGISTRATION: drks-nue.uniklinik-freiburg.de DRKS00003185.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“lithium was shown to increase CORT within few weeks (Bschor et al. 2011)”
From The HPA axis in bipolar disorder: Systematic review and meta-analysis (2016) · cites this paper as Bschor et al. 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971 · cited 1×
“. According to these findings, we expected an effectsize d(z) ( = Cohen's d for dependent measures) of 0.65 for observing an increased cortisol response (AUC) to a second DEX/CRH test after four weeks of lithium treatment. From this effect size, we calculated an optimal sample size of n = 29 under standard assumptions…”
MethodInfluentialAn inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · cited 4×
“The HDRS21, BDI and CGIseverity scores (mean 6 SD) on day 0 were 21.764.70, 24.068.1, and 5.760.7 respectively, and declined to 11.165.1, 15.069.1, and 4.661.2 on day 28 (p,0.001 for all three changes; Wilcoxon’s matched pairs test).”
MethodInfluentialHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 7×
“In accordance with established criteria [50,51], patients were classified as responders if their HDRS21-score showed a decrease of 50% or more in the course of the four-week-study and remission was defined as a HDRS21-score of 7 or less on day 28.”
MethodInfluential(1976) · Medical Entomology and Zoology · Cited by 8,899
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · cited 2×
“The combined DEX/CRH test was performed in accordance with the established research procedure [6,41,52,53,54]: The Lithium Treatment of Depression and DEX/CRH Test”
BackgroundMethodBelmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
The HPA axis in major depression: classical theories and new developments
Pariante, C. M., & Lightman, S. L. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.006 · Cited by 2,009 · cited 2×
“It is well known that most antidepressants lead to deactivation of the HPA system [7,8,58].”
BackgroundClinical Practice Guideline: Otitis Media with Effusion (Update)
Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., et al. (2016) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815623467 · Cited by 2,006
The Structured Clinical Interview for DSM-III-R (SCID): II. Multisite Test-Retest Reliability
Williams, J. B. W. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080038006 · Cited by 1,618 · cited 1×
“Diagnoses were confirmed by the Structured Clinical Interview for DSM IV (SCID I; German version) [43,44,45].”
MethodAntidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation
HOLSBOER, F., & BARDEN, N. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-187 · Cited by 852
The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662 · cited 1×
“The combined DEX/CRH test was performed in accordance with the established research procedure [6,41,52,53,54]: The Lithium Treatment of Depression and DEX/CRH Test”
MethodYatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570 · cited 1×
“. Beside its widespread use in the prophylactic treatment of bipolar”
BackgroundBauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., WFSBP Task Force on Unipolar Depres, Bauer, M., Bschor, T., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 477 · cited 2×
“One of the cornerstones of treatment is antidepressant medication [1,2].”
BackgroundSelf-citationPapakostas, G. I., & Fava, M. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.08.009 · Cited by 382 · cited 1×
“This is, to our knowledge, the first systematic study of lithium monotherapy in treating acute unipolar depression in more than 20 years. Lithium serum levels can be considered as adequate and well-tailored, reaching the therapeutic range after just one week, with a low degree of variance. The response (50%) and remis…”
ResultInfluentialLithium Induces Rapid Relief of Depression in Tricyclic Antidepressant Drug Non-Responders
Dé Montigny, C., Grunberg, F., Mayer, A., & Deschenes, J.-P. (1981) · British Journal of Psychiatry · doi:10.1192/bjp.138.3.252 · Cited by 367 · cited 1×
“a sensitisation of postsynaptic serotonin receptors [59,60].”
Müller-Oerlinghausen, B., Berghöfer, A., & Bauer, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07450-0 · Cited by 331
Reliability of the structured clinical interview for DSM-iII-R: an evaluative review
Segal, D. L., Hersen, M., & Van Hasselt, V. B. (1994) · Comprehensive Psychiatry · doi:10.1016/0010-440x(94)90025-6 · Cited by 293 · cited 1×
“Diagnoses were confirmed by the Structured Clinical Interview for DSM IV (SCID I; German version) [43,44,45].”
MethodResponse and remission criteria in major depression – A validation of current practice
Riedel, M., Möller, H.-J., Obermeier, M., Schennach-Wolff, R., Bauer, M., Adli, M., Kronmüller, K., Nickel, T., Brieger, P., Laux, G., et al. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.03.006 · Cited by 288 · cited 1×
“In accordance with established criteria [50,51], patients were classified as responders if their HDRS21-score showed a decrease of 50% or more in the course of the four-week-study and remission was defined as a HDRS21-score of 7 or less on day 28.”
Method(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.656 · Cited by 278 · cited 2×
“R e sp o n d e rs p (W il co x o n ’s m a tc h e d p a ir s te st ) A C T H (p g /m l) b as e lin e (b e fo re C R H in je ct io n ) 1 4 .1 6 6 1 .8 5 1 8 .6 4 6 1 0 .2 7 0 .0 4 9 1 7 .6 1 6 8 .7 4 1 4 .9 7 6 3 .0 2 0 .8 1 0 .2 2 1 0 .2 3 3 A C T H p e ak 1 9 .5 6 6 3 .6 2 3 1 .1 8 6 3 8 .0 2 0 .9 5 3 5 .3 2 6 3 4 .3…”
Background(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.93 · Cited by 275 · cited 1×
“antidepressants, as tricyclic antidepressants [69,70,71,72,73,74,75] and SSRIs [76,77,78] seem to lead to a blunting of the HPA system response.”
BackgroundThe combined dexamethasone/CRH test as a potential surrogate marker in depression
Ising, M., Künzel, H. E., Binder, E. B., Nickel, T., Modell, S., & Holsboer, F. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.014 · Cited by 271 · cited 3×
“The combined DEX/CRH test was performed in accordance with the established research procedure [6,41,52,53,54]: The Lithium Treatment of Depression and DEX/CRH Test”
BackgroundMethodSelf-citationCrossley, N. A., & Bauer, M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0617 · Cited by 246 · cited 1×
“, lithium in the form of lithium augmentation is a major strategy for treating (unipolar) depression not responding to antidepressant monotherapy”
BackgroundLithium for maintenance treatment of mood disorders
Burgess, S. S., Geddes, J., Hawton, K. K., Taylor, M. J., Townsend, E., Jamison, K., & Goodwin, G. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003013 · Cited by 232 · cited 1×
“Beside its widespread use in the prophylactic treatment of bipolar [14,15,16] and unipolar affective disorder [1,2,17], lithium in the form of lithium augmentation is a major strategy for treating (unipolar) depression not responding to antidepressant monotherapy [18,19].”
BackgroundBoeker, H. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-18088 · Cited by 207
Quiroz, J. A. (2004) · Molecular Interventions · doi:10.1124/mi.4.5.6 · Cited by 206 · cited 1×
“Lithium induces multiple intracellular modifications, which are yet not fully understood [11,12,13].”
BackgroundKunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300868 · Cited by 200
Partial Response and Nonresponse to Antidepressant Therapy: Current Approaches and Treatment Options
Hirschfeld, R. M. A., Montgomery, S. A., Aguglia, E., Amore, M., Delgado, P. L., Gastpar, M., Hawley, C., Kasper, S., Linden, M., Massana, J., et al. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0913 · Cited by 193 · cited 1×
“In accordance with established criteria [50,51], patients were classified as responders if their HDRS21-score showed a decrease of 50% or more in the course of the four-week-study and remission was defined as a HDRS21-score of 7 or less on day 28.”
MethodNot fade away: the HPA axis and depression
Cowen, P. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709005558 · Cited by 191 · cited 5×
“Predominantly this is interpreted as a normalisation of the pathologically-activated HPA system in depressed subjects and seen as a possible way in which antidepressants exhibit their clinical effects [9,41,52,79,80].”
BackgroundResultInfluentialLithium and the Kidney: An Updated Review
Gitlin, M. J. (1999) · Drug Safety · doi:10.2165/00002018-199920030-00004 · Cited by 184
Pariante, C. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04978.x · Cited by 181
Innovative Approaches for the Treatment of Depression: Targeting the HPA Axis
THOMSON, F. J., & Craighead, M. W. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9518-3 · Cited by 171 · cited 3×
“the treatment of depression, however with ambiguous results [9,10].”
BackgroundResultNeuroendocrinological mechanisms of actions of antidepressant drugs
Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167 · cited 5×
“It is well known that most antidepressants lead to deactivation of the HPA system [7,8,58].”
BackgroundMethodInfluentialKeck, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00351-7 · Cited by 167
von Bardeleben, U., Holsboer, F., Stalla, G. K., & Müller, O. A. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90480-1 · Cited by 162 · cited 1×
“Previously, it has been shown that continuous infusion with vasopressin in healthy subjects stimulates the HPA axis and leads to increased ACTH and cortisol responses to the combined DEX/CRH test [64].”
BackgroundPeiffer, A. P., Veilleux, S., & Barden, N. (1991) · Psychoneuroendocrinology · doi:10.1016/0306-4530(91)90034-q · Cited by 156 · cited 1×
“Older cell culture and animal studies [28,29,30,31,32,33,34] showed an enhancing effect of lithium on the release of CRH, AVP, ACHT, and cortisol, and on the glucocorticoid receptor (GR) messenger RNA.”
BackgroundAppelhof, B. C., Huyser, J., Verweij, M., Brouwer, J. P., van Dyck, R., Fliers, E., Hoogendijk, W. J. G., Tijssen, J. G. P., Wiersinga, W. M., & Schene, A. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.008 · Cited by 154
Murgatroyd, C., Wigger, A., Frank, E., Singewald, N., Bunck, M., Holsboer, F., Landgraf, R., & Spengler, D. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1614-04.2004 · Cited by 154 · cited 1×
“Several other findings support central AVP overexpression in these animals [66], which is caused by a genetic variation in the promoter region of the AVP gene [67].”
BackgroundClinical and Neurobiological Effects of Tianeptine and Paroxetine in Major Depression
Nickel, T., Sonntag, A., Schill, J., Zobel, A. W., Ackl, N., Brunnauer, A., Murck, H., Ising, M., Yassouridis, A., Steiger, A., et al. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00008 · Cited by 152 · cited 2×
“R e sp o n d e rs p (W il co x o n ’s m a tc h e d p a ir s te st ) A C T H (p g /m l) b as e lin e (b e fo re C R H in je ct io n ) 1 4 .1 6 6 1 .8 5 1 8 .6 4 6 1 0 .2 7 0 .0 4 9 1 7 .6 1 6 8 .7 4 1 4 .9 7 6 3 .0 2 0 .8 1 0 .2 2 1 0 .2 3 3 A C T H p e ak 1 9 .5 6 6 3 .6 2 3 1 .1 8 6 3 8 .0 2 0 .9 5 3 5 .3 2 6 3 4 .3…”
BackgroundSelf-citationA Controlled Study of the Antidepressant Effects of Lithium Carbonate
Mendels, J. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750200058012 · Cited by 133 · cited 1×
“At least seven studies from the 1970s and 1980s [20,21,22,23,24,25,26] showed that lithium monotherapy is as effective as a tricyclic antidepressant and the two of those studies that included a placebo component [21,23] demonstrated superiority over the placebo (overview: [27]).”
BackgroundThe involvement of the vasopressin system in stress-related disorders
Landgraf, R. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706776359664 · Cited by 127 · cited 1×
“Several other findings support central AVP overexpression in these animals [66], which is caused by a genetic variation in the promoter region of the AVP gene [67].”
BackgroundNikisch, G., Mathé, A. A., Czernik, A., Thiele, J., Bohner, J., Eap, C. B., Ågren, H., & Baumann, P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0034-3 · Cited by 117 · cited 2×
“R e sp o n d e rs p (W il co x o n ’s m a tc h e d p a ir s te st ) A C T H (p g /m l) b as e lin e (b e fo re C R H in je ct io n ) 1 4 .1 6 6 1 .8 5 1 8 .6 4 6 1 0 .2 7 0 .0 4 9 1 7 .6 1 6 8 .7 4 1 4 .9 7 6 3 .0 2 0 .8 1 0 .2 2 1 0 .2 3 3 A C T H p e ak 1 9 .5 6 6 3 .6 2 3 1 .1 8 6 3 8 .0 2 0 .9 5 3 5 .3 2 6 3 4 .3…”
BackgroundHolsboer‐Trachsler, E., Hemmeter, U., Hatzinger, M., Seifritz, E., Gerhard, U., & Hobi, V. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90020-5 · Cited by 113 · cited 1×
“antidepressants, as tricyclic antidepressants [69,70,71,72,73,74,75] and SSRIs [76,77,78] seem to lead to a blunting of the HPA system response.”
BackgroundIntracellular pathways underlying the effects of lithium
Pasquali, L., Busceti, C. L., Fulceri, F., Paparelli, A., & Fornai, F. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833da5da · Cited by 112 · cited 1×
“Lithium induces multiple intracellular modifications, which are yet not fully understood [11,12,13].”
BackgroundThe impact of treatment on HPA axis activity in unipolar major depression
McKay, M. S., & Zakzanis, K. K. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.012 · Cited by 103 · cited 2×
“It is well known that most antidepressants lead to deactivation of the HPA system [7,8,58].”
BackgroundControlled Studies of the Acute Antidepressant Effects of Lithium
Worrall, E. P., Moody, J. P., Peet, M., Dick, P., Smith, A., Chambers, C., Adams, M., & Naylor, G. J. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.135.3.255 · Cited by 100 · cited 1×
“At least seven studies from the 1970s and 1980s [20,21,22,23,24,25,26] showed that lithium monotherapy is as effective as a tricyclic antidepressant and the two of those studies that included a placebo component [21,23] demonstrated superiority over the placebo (overview: [27]).”
BackgroundThe combined DEX-CRH test in treatment course and long-term outcome of major depression
Hatzinger, M., Hemmeter, U., Baumann, K., Brand, S., & Holsboer‐Trachsler, E. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00021-3 · Cited by 99 · cited 2×
“The combined DEX/CRH test was performed in accordance with the established research procedure [6,41,52,53,54]: The Lithium Treatment of Depression and DEX/CRH Test”
BackgroundMethodLithium in Neuropsychiatry: The Comprehensive Guide
(2013) · CRC Press eBooks · doi:10.3109/9780203007051 · Cited by 92
Lithium versus antidepressants in the long-term treatment of unipolar affective disorder
Cipriani, A., Smith, K. A., Burgess, S. S., Carney, S. M., Goodwin, G., & Geddes, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003492.pub2 · Cited by 91 · cited 1×
“Beside its widespread use in the prophylactic treatment of bipolar [14,15,16] and unipolar affective disorder [1,2,17], lithium in the form of lithium augmentation is a major strategy for treating (unipolar) depression not responding to antidepressant monotherapy [18,19].”
BackgroundBschor, T., Adli, M., Baethge, C., Eichmann, U., Ising, M., Uhr, M., Modell, S., Kunzel, H. E., Müller-Oerlinghausen, B., & Bauer, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00323-8 · Cited by 90 · cited 1×
“In a previous study, we investigated a group of unipolar depressed patients (N = 30) who did not respond to a treatment with an antidepressant and who were subsequently treated with lithium augmentation”
BackgroundSelf-citationLithium Carbonate and Plasma Cortisol Response in the Affective Disorders
Platman, S. R. (1968) · Archives of General Psychiatry · doi:10.1001/archpsyc.1968.01740050079013 · Cited by 89 · cited 2×
“With regard to humans, certain older studies with methodological limitations showed an increase of plasma cortisol in affectively ill patients after initiation of lithium therapy [35,36], whilst other did not [37].”
BackgroundAdams, C. E. (2004) · Psychiatric Bulletin · doi:10.1192/pb.28.9.351 · Cited by 82
Laakmann, G., Wittmann, M., Gugath, M., Mueller, O. A., Treusch, J., Wahlster, U., & Stalla, G. K. (1984) · Psychopharmacology · doi:10.1007/bf00432027 · Cited by 78 · cited 1×
“antidepressants, as tricyclic antidepressants [69,70,71,72,73,74,75] and SSRIs [76,77,78] seem to lead to a blunting of the HPA system response.”
BackgroundEfficacy and Mechanisms of Action of Lithium Augmentation in Refractory Major Depression
Bschor, T., & Bauer, M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777947650 · Cited by 73 · cited 1×
“Beside its widespread use in the prophylactic treatment of bipolar [14,15,16] and unipolar affective disorder [1,2,17], lithium in the form of lithium augmentation is a major strategy for treating (unipolar) depression not responding to antidepressant monotherapy [18,19].”
BackgroundSelf-citationDouble-Blind Comparison of Lithium Carbonate and Imipramine in Treatment of Depression
Watanabe, S. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760230125010 · Cited by 71 · cited 1×
“At least seven studies from the 1970s and 1980s [20,21,22,23,24,25,26] showed that lithium monotherapy is as effective as a tricyclic antidepressant and the two of those studies that included a placebo component [21,23] demonstrated superiority over the placebo (overview: [27]).”
BackgroundAntidepressants and hypothalamic-pituitary-adrenocortical regulation
Holsboer, F. (1996) · Endocrine Reviews · doi:10.1210/er.17.2.187 · Cited by 62
Schüle, C., Baghai, T. C., Zwanzger, P., Ella, R., Eser, D., Padberg, F., Möller, H., & Rupprecht, R. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1356-z · Cited by 58 · cited 1×
“In contrast mirtazapine acutely inhibits HPA system activity [82,83].”
BackgroundLithium induces corticotropin secretion and desensitization in cultured anterior pituitary cells.
Zatz, M., & Reisine, T. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.4.1286 · Cited by 55 · cited 3×
“Older cell culture and animal studies [28,29,30,31,32,33,34] showed an enhancing effect of lithium on the release of CRH, AVP, ACHT, and cortisol, and on the glucocorticoid receptor (GR) messenger RNA.”
BackgroundThe stress hormone system is back on the map
Holsboer, F. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0001-y · Cited by 48 · cited 1×
“Predominantly this is interpreted as a normalisation of the pathologically-activated HPA system in depressed subjects and seen as a possible way in which antidepressants exhibit their clinical effects [9,41,52,79,80].”
BackgroundHorstmann, S., Dose, T., Lucae, S., Kloiber, S., Menke, A., Hennings, J., Spieler, D., Uhr, M., Holsboer, F., & Ising, M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.004 · Cited by 44 · cited 1×
“In contrast mirtazapine acutely inhibits HPA system activity [82,83].”
BackgroundSelf-citationBschor, T. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.137 · Cited by 39
Self-citationDeuschle, M., Schmider, J., Weber, B., Standhardt, H., Korner, A., Lammers, C.-H., Schweiger, U., Hartmann, A., & Heuser, I. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199706000-00003 · Cited by 37
Laakmann, G., Hinz, A., Voderholzer, U., Daffner, C., Müller, O. A., Neuhauser, H. K., Neulinger, E., & Wittmann, M. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014477 · Cited by 36 · cited 1×
“antidepressants, as tricyclic antidepressants [69,70,71,72,73,74,75] and SSRIs [76,77,78] seem to lead to a blunting of the HPA system response.”
BackgroundReisine, T., & Zatz, M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb00976.x · Cited by 33 · cited 3×
“Older cell culture and animal studies [28,29,30,31,32,33,34] showed an enhancing effect of lithium on the release of CRH, AVP, ACHT, and cortisol, and on the glucocorticoid receptor (GR) messenger RNA.”
BackgroundEffects of Lithium on the Hypothalamo-Pituitary-Adrenal Axis.
SUGAWARA, M., Hashimoto, K., Hattori, T., Takao, T., Suemaru, S., & Ota, Z. (1988) · Endocrinologia Japonica · doi:10.1507/endocrj1954.35.655 · Cited by 31 · cited 2×
“Older cell culture and animal studies [28,29,30,31,32,33,34] showed an enhancing effect of lithium on the release of CRH, AVP, ACHT, and cortisol, and on the glucocorticoid receptor (GR) messenger RNA.”
BackgroundClinical Outcome after Trimipramine in Patients with Delusional Depression - a Pilot Study
Frieboes, R.-M., Sonntag, A., Yassouridis, A., Eap, C. B., Baumann, P., & Steiger, A. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-38087 · Cited by 30 · cited 1×
“antidepressants, as tricyclic antidepressants [69,70,71,72,73,74,75] and SSRIs [76,77,78] seem to lead to a blunting of the HPA system response.”
BackgroundEffect of Lithium-Carbonate Therapy on Adrenocortical Activity
Sachar, E. J. (1970) · Archives of General Psychiatry · doi:10.1001/archpsyc.1970.01740280016004 · Cited by 29 · cited 1×
“With regard to humans, certain older studies with methodological limitations showed an increase of plasma cortisol in affectively ill patients after initiation of lithium therapy [35,36], whilst other did not [37].”
BackgroundLithium in der Behandlung der akuten Depression
Adli, M., Bschor, T., Canata, B., Döpfmer, S., & Bauer, M. (1998) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2007-995282 · Cited by 28
Self-citationBschor, T., Baethge, C., Adli, M., Eichmann, U., Ising, M., Uhr, M., Modell, S., Kunzel, H. E., Müller-Oerlinghausen, B., & Bauer, M. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00088-2 · Cited by 28 · cited 3×
“In an earlier study with the DEX/CRH test, our group found that lithium augmentation had a clear HPA-system-activating effect in unipolar depressed patients who did not respond to preceding monotherapy with an antidepressant [39,40,42].”
BackgroundResultSelf-citationAnai, H., Ueta, Y., Serino, R., Nomura, M. J., Kabashima, N., Shibuya, I., Takasugi, M., Nakashima, Y., & Yamashita, H. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00887-1 · Cited by 27
Bschor, T., Baethge, C., Adli, M., Eichmann, U., Ising, M., Uhr, M., Müller-Oerlinghausen, B., & Bauer, M. (2003) · Depression and Anxiety · doi:10.1002/da.10078 · Cited by 27 · cited 2×
“In an earlier study with the DEX/CRH test, our group found that lithium augmentation had a clear HPA-system-activating effect in unipolar depressed patients who did not respond to preceding monotherapy with an antidepressant [39,40,42].”
BackgroundSelf-citationSpencer, C. M., Jahng, J. W., Ryu, V., & Houpt, T. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20617 · Cited by 24 · cited 1×
“In addition, the activating effect of lithium on the HPA system might be mediated by direct intracellular effects of lithium on pituitary cells [31,32] and by the induction of gene expression [68].”
BackgroundUnder, J., Fyrö, B., Petlersson, U., & Werner, S. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb01296.x · Cited by 23 · cited 1×
“Not established, though demonstrated effective in several older studies, is lithium monotherapy for the treatment of acute depression. At least seven studies from the 1970s and 1980s”
Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients
Watson, S., Gallagher, P., Smith, M. S., Young, A. H., & Ferrier, I. N. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.02.010 · Cited by 23 · cited 1×
“showed a stimulating effect of lithium on CRH, ACTH and cortisol. In addition, in a cross-sectional study with unipolar and bipolar patients in different mood states, Watson and colleagues found a significantly more pronounced cortisol response in the combined DEX/CRH test when comparing patients taking lithium with t…”
ResultCortisol Changes in Long-Term Lithium Therapy
Smigan, L., & Perris, C. (2008) · Neuropsychobiology · doi:10.1159/000118082 · Cited by 22 · cited 1×
“After long-term lithium treatment, the findings have tended to show a decrease in plasma cortisol levels [38].”
BackgroundLithium versus Placebo in Acute Depression: a Clinical Trial
Khan, M. C., Wickham, E. A., & Reed, J. (1987) · International Clinical Psychopharmacology · doi:10.1097/00004850-198701000-00004 · Cited by 22
Effect of Lithium Chloride on Adrenocortical Function in the Rat
Jacobs, J. J. (1978) · Experimental Biology and Medicine · doi:10.3181/00379727-157-40013 · Cited by 22
Production of cortisol in patients with manic-depressive psychosis treated with Lithium Carbonate.
Platman, S. R., Jg, H., Koss, M., & Wg, K. (1971) · PubMed · Cited by 22
Semba, J., Watanabe, H., Suhara, T., & Akanuma, N. (2000) · Neuroscience Research · doi:10.1016/s0168-0102(00)00180-2 · Cited by 21 · cited 2×
“Older cell culture and animal studies [28,29,30,31,32,33,34] showed an enhancing effect of lithium on the release of CRH, AVP, ACHT, and cortisol, and on the glucocorticoid receptor (GR) messenger RNA.”
BackgroundEnhancement of the 5-HT neurotransmission by antidepressant treatments.
de Montigny, C. (1981) · PubMed · Cited by 18
Lithium Carbonate in the Treatment of Acute Depressive Illness
Khan, M. C. (2015) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000395831 · Cited by 17 · cited 1×
“At least seven studies from the 1970s and 1980s [20,21,22,23,24,25,26] showed that lithium monotherapy is as effective as a tricyclic antidepressant and the two of those studies that included a placebo component [21,23] demonstrated superiority over the placebo (overview: [27]).”
BackgroundThe Antidepressant Effect of Lithium
Arieli, A., & Lepkifker, E. (1981) · Springer eBooks · doi:10.1007/978-94-011-8123-5_6 · Cited by 16 · cited 1×
“At least seven studies from the 1970s and 1980s [20,21,22,23,24,25,26] showed that lithium monotherapy is as effective as a tricyclic antidepressant and the two of those studies that included a placebo component [21,23] demonstrated superiority over the placebo (overview: [27]).”
BackgroundSome aspects of corticosterone metabolism in lithium treated rats
Vatal, M., & Aiyar, A. S. (1983) · Chemico-Biological Interactions · doi:10.1016/0009-2797(83)90074-1 · Cited by 15 · cited 1×
“Older cell culture and animal studies [28,29,30,31,32,33,34] showed an enhancing effect of lithium on the release of CRH, AVP, ACHT, and cortisol, and on the glucocorticoid receptor (GR) messenger RNA.”
BackgroundRecommendations for the safe use of lithium
Berghöfer, A., Grof, P., & Müller-Oerlinghausen, B. (2013) · CRC Press eBooks · doi:10.3109/9780203007051-47 · Cited by 4
Lithium and cellular signal transduction pathways
van Calker, D. (2013) · CRC Press eBooks · doi:10.3109/9780203007051-39 · Cited by 2
Laakmann, G., Daffner, C., Voderholzer, U., & Baghai, T. C. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199201001-00108 · Cited by 1
Cited by
The HPA axis in bipolar disorder: Systematic review and meta-analysis
Belvederi Murri, M., Prestia, D., Mondelli, V., Pariante, C., Patti, S., Olivieri, B., Arzani, C., Masotti, M., Respino, M., Antonioli, M., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.014 · Cited by 391
Cortisol and major depressive disorder-translating findings from humans to animal models and Back
Nandam, L. S., Brazel, M., Zhou, M., & Jhaveri, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00974 · Cited by 265
“Lithium treatment in mood disorders has also been associated with increased cortisol levels in response to dexamethasone and DST challenge without reliably mapping to clinical response (82, 83).”
BackgroundHypothalamic‐Pituitary‐Adrenocortical Axis: Neuropsychiatric Aspects
Jacobson, L. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130036 · Cited by 144
Wells, S., Tremblay, P. F., Flynn, A., Russell, E., Kennedy, J., Rehm, J., Van Uum, S., Koren, G., & Graham, K. (2014) · Stress · doi:10.3109/10253890.2014.930432 · Cited by 93
“For example, lithium has been found to be associated with an increase in cortisol (Bschor et al., 2011), whereas citalopram has been shown to decrease HPA axis activity (Bschor et al., 2012).”
BackgroundValvassori, S. S., Resende, W. R., Dal‐Pont, G., Sangaletti‐Pereira, H., Gava, F. F., Peterle, B. R., Carvalho, A. F., Varela, R. B., Dal‐Pizzol, F., & Quevedo, J. (2017) · Bipolar Disorders · doi:10.1111/bdi.12503 · Cited by 87
Metadata
- Authors
- Bschor, T., Ritter, D., Winkelmann, P., Erbe, S., Uhr, M., Ising, M., & Lewitzka, U.
- Affiliations
- Schlosspark-Klinik (DE)
- Technische Universität Dresden (DE)
- Max Planck Institute of Psychiatry (DE)
- Dalhousie University (CA)
- Corresponding author
- Bschor, Tom
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-11-23
- Volume
- 6
- Issue
- 11
- Pages
- e27613
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3223180
- OpenAlex
- W2017204557
- Cited by
- 23
- References
- 86
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 2 · 2015: 5 · 2014: 8
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Figshare (submittedVersion, cc-by)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- AstraZeneca
- Sanofi
- Bundesministerium für Bildung und Forschung
- Servier
- H. Lundbeck A/S
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- lithium monotherapy, major depressive disorder, hypothalamic-pituitary-adrenal axis, ACTH response, cortisol response, corticotropin-releasing factor, vasopressin, treatment response, depression remission
- MeSH terms
- Adolescent, Adrenocorticotropic Hormone, Adult, Aged, Corticotropin-Releasing Hormone, Demography, Major Depressive Disorder, Dexamethasone, Dose-Response Relationship, Drug, Female, Humans, Hydrocortisone, Lithium, Male, Middle Aged, Treatment Outcome, Diagnostic Techniques and Procedures, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

